Moderna Inc. said Thursday that the U.K. purchased an additional 60 million doses of its COVID-19 vaccine, to be delivered in 2022 and 2023. As part of the agreement, the doses can include boosters, and the U.K. can increase or decrease the number of doses it’s buying by 20%. Moderna’s stock is up 197.3% so far this year, while the broader S&P 500 has gained 21.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Latest posts by Market Watch (see all)
- Barron’s: Michael Jordan jersey from NBA Finals of his ‘magnum opus’ season to be auctioned in September - August 13, 2022
- Help My Career: ‘One of the strongest job markets in the past 50 years’: Want a pay raise? - August 13, 2022
- Mansion Global: Frequent stop-over for William Shakespeare hits the market for £1.5 million - August 13, 2022